Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ABH HealthcareNSE:ABH +9.92%15 3-Year EBITDA Growth Rate is 53.00% as of Mar. 2025, which is 69% below its 10-year median of 173.15. GuruFocus rates NSE:ABH with a GF Score™ of 15/100. The stock has 2 warning signs investors should review. Among 526 Healthcare Providers & Services companies, ABH Healthcare ranks better than 91.44% on this metric.
During the past 12 months, ABH Healthcare's average EBITDA Per Share Growth Rate was 8.10% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 53.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 4 years, the highest 3-Year average EBITDA Per Share Growth Rate of ABH Healthcare was 293.30% per year. The lowest was 53.00% per year. And the median was 173.15% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
ABH Healthcare 3-Year EBITDA Growth Rate Related Terms
NSE:ABH vs : 3-Year EBITDA Growth Rate Comparison
For the Medical Care Facilities subindustry, ABH Healthcare's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ABH Healthcare 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, ABH Healthcare's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where ABH Healthcare's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 53.00% mean?
ABH Healthcare (NSE:ABH) has a 3-Year EBITDA Growth Rate of 53.00% as of Mar. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for ABH Healthcare and its competitors. This is 69% below median its historical median of 173.15. Over the past decade, ABH Healthcare's 3-Year EBITDA Growth Rate has ranged from 53.00 to 293.30. According to the industry distribution chart, ABH Healthcare ranks #45 out of 526 companies in the Healthcare Providers & Services industry, placing it in the top 8.6%.
Is ABH Healthcare's 3-Year EBITDA Growth Rate too high?
ABH Healthcare's current 3-Year EBITDA Growth Rate of 53.00% is 69% below median its 10-year median of 173.15. Over the past 10 years, this metric has ranged from a low of 53.00 to a high of 293.30. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 10.05. ABH Healthcare's value of 53.00% is 427.4% above this industry median. Based on the distribution chart, ABH Healthcare ranks #45 out of 526 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, ABH Healthcare has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does ABH Healthcare's 3-Year EBITDA Growth Rate compare to ?
According to the Healthcare Providers & Services industry distribution chart, ABH Healthcare ranks #45 out of 526 companies for 3-Year EBITDA Growth Rate. This places ABH Healthcare in the top 9% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 10.05. ABH Healthcare's value of 53.00% is 427.4% above this benchmark. Historically, ABH Healthcare's own 3-Year EBITDA Growth Rate has ranged from 53.00 to 293.30 over the past decade. While the company's 10-year median is 173.15 vs. the industry median of 10.05, ABH Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.05, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ABH Healthcare's current 3-Year EBITDA Growth Rate of 53.00% is 427.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for ABH Healthcare and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ABH Healthcare's current 3-Year EBITDA Growth Rate is 53.00%, which is 69% below median its own 10-year median of 173.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ABH Healthcare stock overvalued right now?
ABH Healthcare (NSE:ABH) has a current 3-Year EBITDA Growth Rate of 53.00%. The current 3-Year EBITDA Growth Rate is 53.00%, which is 69% below median its 10-year median of 173.15 and 427.4% above the Healthcare Providers & Services industry median of 10.05. ABH Healthcare's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For ABH Healthcare (NSE:ABH), the current 3-Year EBITDA Growth Rate is 53.00% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ABH Healthcare Ltd is engaged in the business of establishing, maintaining, and assisting healthcare services in India, in the form of Super Speciality Hospitals and allied services such as Laboratories & Diagnostic Centres, Blood Bank and other related services. Its medical services cover specialties such as cardiology, neurology, gastroenterology, urology, pulmonology, nephrology, obstetrics and gynecology, critical care, orthopedics, general and laparoscopic surgery, dentistry, physiotherapy, dermatology, and radiology. The company derives the majority of inpatient revenue from its internal medicine, cardiology, neurosurgery, and orthopedics / joint replacement/trauma services.
15GF Score
Get the complete analysis for NSE:ABH
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ABH has been successfully added to your 
